SS
VYGR icon

Sunbelt Securities’s Voyager Therapeutics VYGR Stock Holding History

Sunbelt Securities’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$181 Buy
47
+11
+31% +$43 ﹤0.01% 2532
2025
Q4 		$141 Hold
36
– – ﹤0.01% 2480
2025
Q3 		$168 Buy
+36
New +$130 ﹤0.01% 2440

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Sunbelt Securities's VYGR Position: Q1 2026 in Review

Sunbelt Securities increased its Voyager Therapeutics (VYGR) stake by 31% in Q1 2026, buying an estimated $43 and bringing the position to 47 shares worth $181. The position accounts for ﹤0.01% of the portfolio, ranked #2532.

Sunbelt Securities first reported a position in VYGR in Q3 2025 and has held it in 3 quarters since. 135 funds tracked by Wall St. Rank hold VYGR as of Q1 2026.

  • Sunbelt Securities held 47 shares of Voyager Therapeutics worth $181 as of Q1 2026.
  • Sunbelt Securities bought 11 Voyager Therapeutics shares in Q1 2026, an estimated $43.
  • Voyager Therapeutics made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #2532 holding.
  • Sunbelt Securities first reported a position in Voyager Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.